Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4962 studies found for:    stage 2 breast cancer
Show Display Options
Rank Status Study
1 Completed Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
Condition: Breast Cancer
Intervention: Drug: docetaxel & capecitabine
2 Completed Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Radiation: radiation therapy
3 Completed Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer
Conditions: Stage II Breast Cancer;   Stage III Breast Cancer
Intervention: Biological: Autologous dendritic cell vaccination
4 Active, not recruiting Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
Condition: Breast Cancer
Intervention:
5 Completed Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: aldesleukin;   Biological: recombinant interferon gamma;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: thiotepa;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
6 Terminated S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: radiation therapy;   Procedure: surgery
7 Completed Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: CMF regimen;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: autologous bone marrow transplantation;   Procedure: surgical procedure;   Radiation: radiation therapy
8 Recruiting Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
Conditions: Breast Cancer;   Breast Cancer Stage II-III
Intervention: Drug: Docetaxel- Carboplatin
9 Recruiting PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: PD0332991;   Drug: Anastrozole;   Drug: Goserelin;   Procedure: Surgery (standard of care);   Procedure: Tumor biopsy
10 Completed Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: busulfan;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: paclitaxel;   Drug: tamoxifen citrate;   Drug: thiotepa;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
11 Active, not recruiting Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Nab-paclitaxel
12 Active, not recruiting Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Condition: Breast Cancer
Interventions: Biological: HER2Bi-armed activated T cells;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel;   Other: laboratory biomarker analysis;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
13 Completed Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Condition: Breast Cancer
Interventions: Drug: DLBS1425;   Drug: Placebo DLBS1425
14 Completed Biomarkers in Women Receiving Chemotherapy and Celecoxib for Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: filgrastim;   Drug: capecitabine;   Drug: celecoxib;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin hydrochloride;   Genetic: gene expression analysis;   Genetic: polymorphism analysis;   Genetic: protein expression analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: imaging biomarker analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: needle biopsy;   Procedure: neoadjuvant therapy;   Procedure: radiomammography;   Procedure: ultrasound imaging
15 Unknown  Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm
Conditions: Breast Cancer;   Chemotherapy
Interventions: Drug: Taxotere , Epirubicin;   Drug: E-HDFL,EP,TE,N-HDFL,NP,T-HDFL,TP
16 Terminated Primary Paclitaxel Plus Gemcitabine in Patients With Stage II and III Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Paclitaxel/Gemcitabine
17 Completed Paclitaxel and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Post-operative adjuvant therapy;   Drug: neoadjuvant therapy;   Procedure: therapeutic surgical procedure;   Radiation: Radiation therapy with concurrent Paclitaxel;   Drug: Hormonal Therapy
18 Completed
Has Results
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients
Condition: Breast Neoplasm
Interventions: Drug: epirubicin;   Drug: cyclophosphamide;   Drug: docetaxel;   Drug: trastuzumab
19 Completed Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
Condition: Breast Cancer
Interventions: Biological: pegfilgrastim;   Drug: carboplatin;   Drug: docetaxel;   Procedure: conventional surgery
20 Terminated
Has Results
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   HER2-negative Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: goserelin acetate;   Drug: letrozole;   Drug: anastrozole;   Drug: chemotherapy;   Procedure: Surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.